Spotlight -

Long-Acting Injectable Therapy in the Management of Adult Patients with Schizophrenia|

Major Depressive Disorder

Paras Gupta, MBE

Articles by Paras Gupta, MBE

Ktsdesign/AdobeStock

The Impact of Selective Serotonin Reuptake Inhibitors on Bleeding Risk: A Comprehensive Review

ByParas Gupta, MBE,Sarah Hakam, BS,Arsalan Nisar, MS,Inna D'Empaire, MD,Gina Jamal, MD,Reza Safavi, MD

February 3rd 2025

What patients are at risk when taking SSRIs?

Latest Updated Articles

The Impact of Selective Serotonin Reuptake Inhibitors on Bleeding Risk: A Comprehensive Review
February 3rd 2025

Trending on Psychiatric Times

DT120 (Lysergide) ODT Receives Breakthrough Therapy Designation for Treatment of MDD

New 52-Week Topline Open-Label Data from Phase 3 COMP005 Trial: The Power of Another COMP360 Dose

The Postmodern Worldview and Contemporary Psychiatry

New Phase 3 Data on Oveporexton for Narcolepsy Type 1

Choosing Sexual Function-Sparing Medications